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Abstract
This study aimed to investigate if food components that exert anti-inflammatory effects may be
used for inflammatory disorders by examining alfalfa sprout ethyl acetate extract (ASEA). The
cytokine profile and life span of BALB/c mice with acute inflammation after intra-peritoneal (ip)
injection of 15 mg/kg BW lipopolysaccharide (LPS) were determined. The results showed that the
life span of LPS-induced inflammatory mice were negatively correlated with serum levels of TNF-
α, IL-6, and IL-1β at 9 hr after LPS-injection, which indicated that suppressing these cytokines in
the late phase of inflammation may be beneficial for survival. The in vitro experiment then showed
that ASEA significantly reduced IL-6 and IL-1β production and the NF-κB trans-activation activity
of mitogen-stimulated RAW264.7 cells. To further evaluate the anti-inflammatory effects of ASEA
in vivo, BALB/c mice were tube-fed with 25 mg ASEA/kg BW/day in 50 μl sunflower oil, while the
control and PDTC (pyrrolidine dithiocarbamate, an anti-inflammatory agent) groups were tube-fed
with 50 μl sunflower oil/day only. After one week of tube-feeding, the PDTC group was injected
with 50 mg/kg BW PDTC and one hour later, all of the mice were injected with 15 mg/kg BW LPS.
The results showed that the ASEA and PDTC groups had significantly lower serum TNF-α, IL-6,
and IL-1β levels at 9 hr after LPS challenge, and significantly higher survival rates than the control
group. This study suggests that ASEA supplementation can suppress the production of pro-
inflammatory cytokines and alleviate acute inflammatory hazards.
Background
There is growing evidence that systemic inflammation is
associated with increased risk of chronic diseases such as
cardio-vascular disease, cancer, and insulin resistance [1-
3]. The mechanisms may involve macrophage and T lym-
phocyte activation, as well as release of pro-inflammatory
cytokines that amplify the inflammatory activity [4,5].
Inflammation can be mediated by pro-inflammatory
mediators, including tumor necrosis factor (TNF)-α, inter-
leukin (IL)-1, IL-6, interferon (IFN)-γ, IL-12, IL-18, nitric
oxide, and cell adhesion molecules [6]. These mediators
help the innate immune response but their overproduc-
tion results in acute phase endotoxemia that causing tis-
sue injury, organ failure, shock, and even death [7,8].
Among these mediators, pro-inflammatory cytokines
such as TNF-α, IL-6, and IL-1β, are activated through NF-
κB but they also activate NF-κB, thus amplifying the
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cytokine cascade and expanding the inflammatory status
[9,10]. Because they play a driving role in the inflamma-
tory process, effectively modulating their aberrant produc-
tion can be beneficial in reducing inflammatory diseases.
Therefore, the application of dietary components aside
from anti-inflammatory drugs has recently become a
focus of interest [11-13]. Dietary strategies have been
recently proposed, including an anti-inflammatory diet
for the prevention of chronic diseases associated with
inflammation [14].
Alfalfa (Medicago sativa L.) sprouts are often consumed as
vegetable salad. Its leaves or seeds are also sold as bulk
powdered herb, capsules, and tablets for nutritional sup-
plement in health food stores [15]. The extracts from
alfalfa sprouts, leaves, and roots have been indicated to be
helpful in lowering cholesterol levels in animal and
human studies [16-18]. In addition, traditional medicinal
use of alfalfa sprouts or leaves includes treatment of
arthritis, kidney problems, and boils [19,20]. However,
these treatments still need to be scientifically examined.
Our previous study showed that the ethyl acetate extract of
alfalfa sprouts ameliorates the autoimmune-prone disease
of lupus mice, probably by attenuating cytokine and
inflammatory responses [21]. Therefore, this study aimed
to investigate the anti-inflammatory effect of the ethyl ace-
tate extract of alfalfa sprouts with in vitro cell culture and
through in vivo LPS-induced inflammatory mice.
Materials and methods
Reagents and materials
The reagents lipopolysacharide (LPS, E. coli serotype
O55:B5), pyrrolidine dithiocarbamate (PDTC), and con-
canavalin (Con) A (Sigma Chemical Company; St. Louis,
MO, USA) were all analytical grade and dissolved in phos-
phate buffer saline as a stock. Fresh alfalfa sprouts (Medi-
cago sativa L.) (Goboul-Grange LTD; Taipei, Taiwan) were
freeze-dried and finely grounded into the powder. The
proximate composition of this powder was 33.6% carbo-
hydrate, 49.6% protein, 2.6% lipid, 10.5% water, and
3.7% ash. Alfalfa sprout powders were extracted with
ethyl acetate (EA 1:40, w/v, g/ml) by stirring at room tem-
perature for 2 days. The sampled solvent solutions were
collected and filtered through filter paper (Whatman No.
2; Whatman Paper Ltd, Maidstone). The alfalfa sprouts
ethyl acetate extract (ASEA) was obtained by removing the
solvent in a rotary evaporator, with a yield of 43.1 mg/g,
and stored at -20°C.
Cell culture experiment
The RAW264.7 cells (Bioresource Collection and Research
Center; Hsinchu, Taiwan) were cultured in DMEM con-
taining 10% fetal bovine serum (FBS), 2 mM glutamine,
1% non-essential amino acid, and 1 mM sodium pyru-
vate, and maintained in a humidified incubator at 37°C
in 5% CO2. In this experiment, the RAW264.7 cells were
seeded on 6-cm dishes at cell density of 2 × 106 cells/ml
for NF-κB binding activity and mRNA expression, or 96-
well plates at cell density of 2 × 104 cells/200 μl/well. The
cells were then pre-treated with various concentrations of
ASEA or PDTC (100 μM) for 1 hr before adding 100 ng/
ml LPS for stimulated incubation. This PDTC concentra-
tion was shown to suppress cytokine production in
RAW264.7 cells according to a previous report [22]. ASEA
was dissolved in absolute ethanol for cell treatment (final
ethanol concentration ≤ 0.1% in medium) and had no
direct toxic effect on either RAW264.7 cells or primary
macrophages.
For NF-κB binding activity and cytokine mRNA expres-
sion, the cells were lysed to obtain nuclear extracts and
total RNA, respectively, after 24-hr incubation. For
cytokine production, cell supernatants were collected for
cytokine assay after 48-hr incubation, and cells at the bot-
tom were assessed for viability.
For primary macrophage cell culture, peritoneal exudate
cells isolated from BALB/c mice were seeded on 96-well
plates at cell density of 2 × 105 cells/200 μl/well. Non-
adherent cells were removed after 3 hr-incubation while
adherent cells were pre-treated with various concentra-
tions of ASEA (2, 10, and 50 μg/ml) 1 hr before addition
of 10 μg/ml LPS for stimulation. Cell supernatants were
collected for cytokine assay after 48-hr incubation. Three
independent experiments were performed for all of the in
vitro cell cultures.
RNA isolation, reverse transcription and real-time PCR
The experiment was conducted according to a previous
study [23]. RNA was isolated from RAW264.7 cells (> 5 ×
106 cells) using the Trizol method (Invitrogen, Carlsbad,
CA, USA) and reverse transcribed using 4 μg of total RNA,
10 mM dNTP (Takara, Shiga, Japan), 0.25 μg oligo dT
(Promega, Madison, WI), 5 × M-MLV reaction buffer, and
200 U of M-MLV reverse transcriptase (Promega) in a final
volume of 15 μl. The reaction was conducted for 1 hr at
42°C, followed by 5 min at 90°C, and slowly cooled to
4°C for 10 min.
The products were subjected to real-time PCR with primer
sets of specific genes and SYBR Green PCR Master Mix
(Bio-Rad Laboratories Inc., Hercules, CA, USA). The
primer set used for mouse IL-6 was 5'-ACAGAAGGAGT-
GGCTAAGGAC-3' and 5'-GCTTAGGCATAACG-
CACTAGG-3'. The primer sets used as internal controls
were 5'-CTATTGGCAACGAGCGGTTCC-3' and 5'-
GCACTGTGTTGGCATAGAGGTC-3' for β-actin and 5'-
TGTGTCCGTCGTGGATCTGAC-3' and 5'-GATGCCTGCT-
TCACCACCTTC-3' for GAPDH. The results were deter-
mined by a comparative Ct value and analyzed with theJournal of Biomedical Science 2009, 16:64 http://www.jbiomedsci.com/content/16/1/64
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iCycler iQ real-time PCR detection system (Bio-Rad Labo-
ratories Inc.). The Ct value of the control was used as a ref-
erence. All PCR-reactions were run in duplicate.
NF-κB-dependent reporter assays
Transcriptional activation in the NF-κB binding site was
assayed using a reporter plasmid, 3x-κB-tk-luciferase, con-
taining three copies of the κB binding site in the upstream
thymidine kinase (tk) promoter and a luciferase reporter
gene in the pRL vector [24] (Dr. M. Kashiwada, NIH,
Japan). Briefly, RAW264.7 cells were seeded on a 24-well
plate at 1 × 105 cells/ml/well. Adherent cells were cultured
for 18 hr and then transfected with 0.2 μg 3x-κB-tk-luci-
ferase and 0.1 μg pRL-tk-luciferase (2:1) in 100 μl serum-
free medium OPTI-MEM (Gibco BRL, Gaithersburg, MD,
USA) containing 1 μl Lipofectamine™ 2000 (Invitrogen)
per well. After 5 hr, the medium was changed to serum-
free OPTI-MEM containing 100 ng/ml LPS and 1000
units/ml IFN-γ (Sigma) in the absence or presence of the
different concentrations of ASEA. After 8 hr-incubation,
the supernatants were removed and the luciferase reporter
gene was analyzed.
Luciferase reporter assays were carried out according to
the manufacturer's instructions [25]. Light emission was
measured in a luminescence micro-plate counter (Wallac
Victor-2 Perkin Elmer, Norwalk, MT, USA). Luciferase
activity, expressed in arbitrary light units, was corrected
for protein concentration in the sample, followed by nor-
malization of transfection efficiency by β-galactosidase
activity. The experiments were repeated thrice and showed
the same tendency.
Detection of NF-κB DNA-binding activity
Nuclear protein extracts and NF-κB DNA-binding activity
in LPS-stimulated RAW264.7 cells were conducted by
commercial kit (Active Motif, Carlsbad, CA, USA). Cells
were washed twice with PBS/phosphatase inhibitor buffer
and cell pellets were collected. Cells were re-suspended in
hypotonic buffer on ice, and then reacted with Nonidet P-
40. Nuclei were pelleted by centrifugation at 14000 × g for
30 sec. The pellet containing nuclei was re-suspended in
extraction buffer (with protease inhibitor) and gently
rocked on a shaking platform. By centrifugation at 14000
× g for 10 min, supernatants containing nuclear proteins
were collected.
Protein concentrations of the nuclear lysates were deter-
mined using bicinchoninic acid assay. (Pierce Chemical
Co., Rockfold, IL, USA). The DNA-binding activity of the
p65 subunit of NF-κB in the nuclear protein extract was
assessed using NF-κB p65 TransAM assay according to the
manufacturer's instructions (Active Motif). Briefly, oligo-
nucleotides containing the NF-κB consensus sequence
were immobilized on a 96-well plate, which was incu-
bated with the indicated nuclear protein extracts (2.5 μg/
sample) for 1 hr at room temperature and shaken at 100
rpm. The plate was then washed and incubated with anti-
bodies against p65 for 1 hr. After extensive washes, the
plate was subsequently incubated with peroxidase-conju-
gated secondary antibodies for 1 hr. The peroxidase activ-
ity was visualized by tetramethylbenzidine reaction and
the absorbance at 450 nm was determined using ELISA
reader (EL311, Bio-TEK Inc., Winooski, VT, USA).
Animal experiment and LPS-challenged acute 
inflammation
Five- to 6-week-old-female BALB/c mice from the Animal
Center of the College of Medicine at National Taiwan Uni-
versity (Taipei, Taiwan) were maintained in an air-condi-
tioned room at 23 ± 2°C on a regulated 12-hr light-dark
cycle and housed in stainless steel cages with glass water
bottles, and fed AIN-76 diet [26]. At age of 10 wks, the
mice were started on experimental treatment or diet sup-
plementation. Animal care and handling conformed to
the National Institutes of Health's Guide for the Care and
Use of Laboratory Animals [27].
To obtain the serum cytokine profile during acute inflam-
mation, thirty 10-week-old BALB/c mice were injected
intra-peritoneally (ip) with 15 mg/kg body weight (BW)
LPS. Sera were obtained from 3–4 mice by retro-orbital
bleeding at each time point of 0, 1.5, 2, 4, 6, 9, 12, and 24
hr after LPS challenge without repeat bleeding from the
same mouse. To investigate the correlation between
serum pro-inflammatory cytokine levels and life span,
sera from sixty-six 10-week-old BALB/c mice were col-
lected at 2 and 9 hr after 15 mg/kg BW LPS challenge, and
the life spans of these mice were recorded.
ASEA supplement prior to LPS-induced acute 
inflammation
Forty 10-week-old BALB/c mice were divided into three
groups: the control (n = 15) and PDTC (n = 9, as a positive
control) groups were tube-fed with 50 μl sunflower oil
(SO)/day, while the ASEA group (n = 16) were tube-fed
with 25 mg/kg BW ASEA in 50 μl SO/day. This oral dose
of ASEA was derived from the effective dose (50 μg/ml) in
primary peritoneal macrophage according to a previous
report [28]. The PDTC group had fewer mice because this
positive control group has been repeated and showed sim-
ilar results in different experiments in our laboratory. The
mice had free access to AIN-76 diet and water and were
additionally tube-fed with either SO or ASEA daily. After
one week of tube feeding, all of the mice were injected ip
with 15 mg/kg BW LPS to induce acute inflammation.
Mice in the PDTC group were injected ip with 50 mg/kg
BW PDTC, a dose with anti-inflammatory effects as
reported, 1 hr before LPS challenge [29,30]. Sera were col-
lected at 2 and 9 hr after LPS challenge for cytokine assay.Journal of Biomedical Science 2009, 16:64 http://www.jbiomedsci.com/content/16/1/64
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The life spans of mice that continued on AIN-76 diet ad lib
were recorded.
Assay of cytokine production
The production of cytokines TNF-α, IL-6, and IL-1β in the
cell supernatants and mice serum was assayed by com-
mercial ELISA kit. Briefly, anti-IL-6 (BD Pharmingen, San
Diego, CA, USA), TNF-α, or IL-1β (R and D, Minneapolis,
MN, USA) antibodies were coated to 96-well plates. After
incubation, the wells in the plate were washed and
blocked with blocking solution (PBS buffer containing
1% bovine serum albumin; Sigma), and then washed and
properly diluted supernatant or serum was added. After
incubation, the wells were washed and biotin-conjugated
anti-IL-6, TNF-α, or IL-1β antibodies were added for 2 hr.
The wells were then washed and horseradish peroxidase-
conjugated streptavidin (Pierce Chemical Co.) was added
for 30 min, washed, and incubated with ABTS (2, 20-
azino-bis (3-ethylbenzthazoline-6-sulfonic acid), Sigma)
or TMB (tetramethylbenzidine; Clinical Science Products,
Mansfield, MA, USA). Absorbance at 405 nm or 620 nm
was measured using ELISA reader (EL311, Bio-TEK Inc.).
The data were calculated according to the cytokine stand-
ard curve.
Statistical analysis
Data were expressed as mean ± SD or mean ± SEM. Signif-
icant difference compared to the control group was ana-
lyzed by the Student's t-test using the SAS software
program (SAS/STAT version 8.0; SAS Institute, Cary, NC,
USA). The relationship between serum pro-inflammatory
cytokine level and survival was analyzed by simple corre-
lation of the SAS program. Statistical comparison between
different survival curves was analyzed by COX's propor-
tion hazards regression test (STATA version 6.0; Stata
Corp., College Station, TX, USA). A P value less than 0.05
was considered statistically significant.
Results
Serum pro-inflammatory cytokine release in LPS-
challenged mice
To investigate changes of cytokines in acute inflamma-
tion, serum levels of pro-inflammatory cytokines were
determined at different time points after 15 mg/kg BW
LPS challenge in BALB/c mice. Serum TNF-α level peaked
at 1.5 hr (6.86 ± 0.25 ng/ml) and then quickly declined to
the base level over 12 hr (0.16 ± 0.05 ng/ml) (Figure 1A).
Serum IL-6 and IL-1β reached the highest levels at 4 hr
(774 ± 22 ng/ml and 783 ± 234 pg/ml), dropped at 9 hr,
and remained detectable at 24 hr (57.1 ± 41.7 ng/ml and
135 ± 25 pg/ml) (Figures 1B and 1C).
Negative correlation between life span and serum cytokine 
levels in acute inflammation
In order to investigate the association of serum cytokine
level in the early and late phases of acute inflammation
with life span of LPS-induced inflammatory mice, sera at
2 and 9 hr after LPS-challenge were obtained for TNF-α,
IL-6, and IL-1β measurement. The correlation between life
span and serum cytokine level was analyzed (Figure 2). At
2 hr after LPS-challenge, only serum TNF-α level nega-
tively correlated with life span (r = -0.403, p = 0.002),
while at 9 hr, serum levels of TNF-α, IL-6, and IL-1β all
negatively correlated with life span (r = -0.295, p = 0.026
for TNF-α; r = -0.538, p < 0.001 for IL-6; r = -0.301, p =
0.022 for IL-1β).
ASEA inhibited pro-inflammatory cytokine production 
from LPS-stimulated RAW264.7 cells and peritoneal 
macrophages
In the preliminary test for anti-inflammatory effect of
alfalfa sprouts, extract in ethyl acetate rather than metha-
nol or hexane showed suppressive effects on TNF-α, IL-6,
and IL-1β production by LPS-stimulated primary macro-
phage cells (data not shown). This was the rationale for
selecting alfalfa sprout extract in ethyl acetate (ASEA) for
further study. The pre-treatment of RAW264.7 cells and
primary peritoneal macrophages with 2, 10, 50 μg/ml
ASEA or 100 μM PDTC for 1 hr had no significant effect
on cell viability (data not shown).
As shown in Table 1, the anti-inflammatory reagent
PDTC, as a positive control, suppressed TNF-α and IL-6
production at a concentration of 100 μM (90% and 55%
inhibition, respectively). ASEA at a concentration of 50
μg/ml significantly inhibited IL-6 and IL-1β production in
both LPS-stimulated RAW264.7 cells (51% and 63% inhi-
bition, respectively) and peritoneal macrophages (55%
and 38% inhibition, respectively). Further investigation
of mRNA expression also showed lower IL-6 mRNA in
LPS-stimulated RAW264.7 cells pre-treated with 50 μg/ml
ASEA (78% inhibition) (Figure 3A).
To test whether ASEA pre-treatment may involve NF-κB
activation, a reporter gene assay with 3x-κB-tk-luciferase
after transfection into RAW264.7 cells was performed
(Figure 3B). Pre-treatment of RAW264.7 cells with ASEA
suppressed NF-κB activation, significantly lower at con-
centration of 50 μg/ml (23% inhibition). The p65 subunit
of NF-κB, also known as RelA, contained an important
trans-activating domain for NF-κB-mediated gene activa-
tion [25]. Its significantly lower binding activity was also
observed (Figure 3C).Journal of Biomedical Science 2009, 16:64 http://www.jbiomedsci.com/content/16/1/64
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Time-course of the production of pro-inflammatory cytokines, TNF-α, IL-6, and IL-1β, in the serum in BALB/c mice with LPS  challenge (intra-peritoneal injection 15 mg/kg BW per mouse) Figure 1
Time-course of the production of pro-inflammatory cytokines, TNF-α, IL-6, and IL-1β, in the serum in BALB/c 
mice with LPS challenge (intra-peritoneal injection 15 mg/kg BW per mouse). Each time point value was an average 
of data from 3–4 mice and shown as mean ± SEM.Journal of Biomedical Science 2009, 16:64 http://www.jbiomedsci.com/content/16/1/64
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The correlation between serum cytokine levels (at two time points, 2 hr and 9 hr, after LPS injection) and life span in BALB/c  mice with LPS challenge Figure 2
The correlation between serum cytokine levels (at two time points, 2 hr and 9 hr, after LPS injection) and life 
span in BALB/c mice with LPS challenge. This correlation was analyzed by the simple correlation in SAS 8.0 software (n 
= 64, p < 0.05).
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Effects of ASEA on IL-6 mRNA expression and NF-κB activation in LPS-stimulated RAW264.7 cells Figure 3
Effects of ASEA on IL-6 mRNA expression and NF-κB activation in LPS-stimulated RAW264.7 cells. (A) Cells 
pre-treated with 0 (control), 10, 20 or 50 μg/ml ASEA for 1 hr were stimulated with LPS for IL-6 mRNA expression by real-
time PCR. (B) Cells transfected with the 3x-κB-tk-luciferase and pRL-tk-luciferse plasmids were stimulated with LPS and IFN-
γ in the absence (0) or the presence of 2, 10, and 50 μg/ml ASEA for the reporter assay. (C) Nuclear extracts from unstimu-
lated (spontaneous) or LPS-stimulated cells pre-treated with 0, 20, or 50 μg/ml ASEA were for DNA-binding activities of the 
NF-κB subunit, p65. Bar values are mean ± SD in three independent experiments in these assays. A significant difference from 
the control was indicated as *p < 0.05 or **p < 0.01 by Student's t-test.Journal of Biomedical Science 2009, 16:64 http://www.jbiomedsci.com/content/16/1/64
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ASEA reduced serum levels of pro-inflammatory cytokines 
in LPS-challenged mice
For the in vivo study, mice were tube-fed 25 mg/kg BW/day
ASEA for one-week and challenged with LPS to induce
acute inflammation. Sera were collected at 2 and 9 hr after
LPS-challenge for pro-inflammatory cytokine assay (Table
2). The PDTC positive control group had significantly
lower serum levels of cytokines, except for IL-6 level at 2
hr after LPS challenge, compared to the control group. The
ASEA group also had lower serum levels of TNF-α, IL-6,
and IL-1β, especially significant at 9 hr after LPS injection
compared to the control.
ASEA supplement benefited survival of LPS-challenged 
mice
To investigate whether suppression of pro-inflammatory
cytokine production may benefit survival of LPS-chal-
lenged mice, the life spans were recorded (Figure 4). Only
half of the mice survived at 24 hr after LPS challenge in the
control group, but approximately three-fourths (12 of 16
mice) in the ASEA group survived. At 48 hr, 50% (8/16)
in the ASEA group survived as compared to 13% (2/15) in
the control group. The survival rate in the ASEA group was
significantly higher than that of the control group accord-
ing to the COX's proportion hazards regression test (haz-
ard ratio = 0.37, p = 0.03). The PDTC group also had a
higher survival rate (hazard ratio = 0.07, p = 0.01).
Discussion
In normal conditions without any stimuli or treatment,
serum TNF-α and IL-1β levels are barely detectable, while
IL-6 level at 1~2 ng/ml is detectable in BALB/c mice [31].
After LPS challenge, serum TNF-α levels quickly rises, fol-
lowed by IL-1β and IL-6 [32]. However, the induced ele-
vation and release of these pro-inflammatory cytokines
may vary according to the animal species and LPS dosage
used. Most studies use low dose LPS (5 mg/kg BW) for
cytokine profile and high doses (35~44 mg/kg BW) for
survival studies [29,31,33]. The current study utilized a
sub-lethal dose of 15 mg/kg BW according to a dose titra-
tion study showing mice with 100% survival at 14 hr and
50% survival at 24 hr after LPS challenge, which allows for
examining the profile of cytokines not only at the early
but also at the late stage of LPS-induced acute inflamma-
tion.
Table 1: Effects of ASEA on pro-inflammatory cytokines production from LPS-stimulated RAW264.7 cells and peritoneal 
macrophages.
Treatment RAW 264.7, ng/mla Macrophages, ng/mlb
IL-1β IL-6 TNF-α IL-1β IL-6 TNF-α
Control (0) 0.16 ± 0.02 36.3 ± 1.61 12.3 ± 2.63 1.22 ± 0.22 36.3 ± 5.75 1.67 ± 0.21
ASEA 2 μg/ml 0.19 ± 0.01 32.1 ± 0.62 10.9 ± 4.01 1.13 ± 0.24 41.6 ± 9.12 1.77 ± 0.25
ASEA 10 μg/ml 0.17 ± 0.02 20.8 ± 2.88* 14.6 ± 2.71 1.06 ± 0.32 34.6 ± 6.68 1.44 ± 0.29
ASEA 50 μg/ml 0.06 ± 0.01* 17.4 ± 5.81** 14.3 ± 1.72 0.76 ± 0.24* 16.4 ± 5.55* 1.41 ± 0.15
PDTC100 μM 0.14 ± 0.03 15.9 ± 3.24** 1.58 ± 0.39** N.D.c
Values are expressed as means ± SD of three independent experiments with triplicates each and statistically analyzed by using Student's t-test. A 
significant difference from the control was indicated *p < 0.05.
aRAW264.7 cells were stimulated 100 ng/ml LPS for 48-hr incubation.
bMurine peritoneal macrophages were stimulated with 10 μg/ml LPS for 48-hr incubation.
cN.D. means no detection in cytokine profile of peritoneal macrophages.
Table 2: The effect of ASEA supplement on the production of pro-inflammatory cytokines in serum of LPS-challenged BALB/c mice.
Cytokine Time after LPS Control ASEA PDTC
n = 15 n = 16 n = 9
Serum cytokine levels, ng/ml
TNF-α 2 hr 7.51 ± 1.37 5.63 ± 1.01 0.87 ± 0.32 **
9 hr 0.63 ± 0.09 0.31 ± 0.06 * 0.16 ± 0.03 *
IL-6 2 hr 286 ± 28 235 ± 15 299 ± 19
9 hr 307 ± 43 145 ± 26 ** 49 ± 43 **
IL-1β 2 hr 0.21 ± 0.01 0.19 ± 0.01 0.18 ± 0.01 *
9 hr 0.38 ± 0.05 0.23 ± 0.03 * 0.12 ± 0.03 **
Sera at 2 hr and 9 hr after LPS injection were collected for cytokines assay. The cytokine production in serum was assayed by ELISA. Values are 
means ± SEM. *p < 0.05, **p < 0.01, significantly different from the control group analyzed by Student's t-test.Journal of Biomedical Science 2009, 16:64 http://www.jbiomedsci.com/content/16/1/64
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This study is the first to illustrate the cytokine profile of
BALB/c mice with 15 mg/kg BW LPS challenge (Figure 1).
Data showed that peak levels of serum TNF-α are similar,
but the several hundred-fold increase of IL-6 and IL-1β
were different from other studies [29,31,33]. Serum TNF-
α peaked at 1.5 hr after LPS injection and at 1 or 1.5 hr in
studies with similar levels (~7 ng/ml) despite varying
mice species and LPS dosage [34]. This suggests that TNF-
α is the pro-inflammatory cytokine that responds most
rapidly, reaches certain peak levels in blood, and drops
after exerting its function [29,32]. Serum IL-6 showed
higher peak levels and peaked at 4 hr after LPS challenge
in our study rather than 2~3 hr with various peak levels in
other studies [33,35]. Serum IL-1β levels were higher and
reached peak levels at 4 hr after LPS challenge in our study
compared to those of others studies peaking at 2~6 hr
with the same LPS dosage but different mice species
[31,33,34]. Therefore, overall, the time point of 2 hr after
LPS challenge was chosen for further investigation of the
correlation between early cytokine production and life
span.
In addition, there were detectable sera TNF-α, IL-6, and IL-
1β at 9 hr after LPS challenge with a dose of 15 mg/kg BW,
which was different from other studies in which these
cytokines were almost undetectable when 5 mg/kg BW
was used. This provides further insight into the anti-
inflammatory effect in late stage LPS-induced acute
inflammation. The findings here suggest that the LPS dose
of 15 mg/kg BW is an optimal challenge dose for studying
both cytokine profile and survival. The effects elicited by
this dose can be modulated by food components.
Survival rate in murine endotoxic shock has been used as
an indicator of anti-inflammatory effect. However, it
remains unclear if the early or late evocation of serum
TNF-α, IL-1β, and IL-6 is crucial for survival. In the current
study, cytokine levels in serum obtained at 2 and 9 hrs
after LPS challenge and life spans were followed using the
same batch of mice to evaluate the association of serum
cytokine levels and survival (Figure 2). The results show
that TNF-α level at 2 hr negatively correlates with life
span, suggesting that down-regulating serum TNF-α in the
early stage of acute-inflammation may prolong the life of
mice suffering from endotoxic shock by LPS injection.
Suppression of TNF-α production by some plant extracts,
such as Dioscoreae Rhizoma, Prunella vulgaris, and Salvia
miltiorrhiza bunge is suggested to ameliorate several
inflammatory disorders, including rheumatoid arthritis,
endotoxemia, and anaphylaxis [35-37]. Potential mecha-
Effects of ASEA supplementation on the survival of mice challenged with 15 mg/kg BW LPS Figure 4
Effects of ASEA supplementation on the survival of mice challenged with 15 mg/kg BW LPS. The ASEA and 
PDTC positive control groups had increased survival using the analysis of COX's proportion hazards regression test (p = 0.03 
and p = 0.01, respectively).
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nisms have been proposed to inhibit signal transductions,
such as protein kinase C, tyrosine kinase, and activation of
NF-κB [38,39].
Interestingly, IL-6, IL-1β, or TNF-α level at 9 hr is also neg-
atively correlated with life span. This implies that inhibit-
ing the subsequent production of pro-inflammatory
cytokines (the later stage) still benefits animal survival.
The correlation is consistent with the observation that one
week pre-treatment of ASEA only significantly decreased
serum levels of pro-inflammatory cytokines at 9 hr after
LPS challenge but could still prolong life in inflammatory
mice (Table 2). PDTC, known to inhibit NF-κB, has been
demonstrated to protect mice from lethal endotoxic shock
when ip injected 30 min or 1 hr prior to the induction
[29,30]. PDTC, as the positive control group in the
present study, significantly suppressed serum TNF-α and
IL-1β not only at 9 hr but also at 2 hr after LPS-challenge,
and thus had the least mortality among the three groups
(Figure 4).
As for anti-inflammation food materials, recent studies
show that components from food sources such as apples,
Ganoderma tsugae, and walnuts may provide anti-inflam-
matory activity and offer nutritional benefits in inflamma-
tion [14,40,41]. Therefore, dietary components and
nutritional supplement have also been proposed to func-
tion in a manner that prevents certain inflammatory dis-
eases, suggesting that more investigations on beneficial
food components and mechanisms of actions are war-
ranted. These food materials, including ASEA in this
study, were administered orally to decrease inflammatory
responses. It has been documented that mucosal immune
mediators such as transforming growth factor-α (TGF-α)
and IL-10 can exert a down-regulatory effect of immune
response [42,43]. More studies are needed to confirm that
oral delivery of ASEA activates certain immune effector
cells and induces the immune response to down-regulate
the inflammatory responses.
Macrophage cell lines, such as murine RAW264.7 cell and
human THP-1 cells, have been used as rapid in vitro
screening methods to study the anti-inflammatory agent
[44]. In the present study, RAW264.7 cells and murine
peritoneal macrophages were used for in vitro screening.
PDTC, as a positive control, significantly decreased IL-6
and TNF-α, but not IL-1β production from LPS-stimulated
RAW264.7 cells (Table 1). This is consistent with other
reports though different cells like the J774A.1 murine
macrophage-like cell line and peritoneal macrophages
were used [29].
Similarly, 50 μg/ml ASEA pre-treatment also significantly
suppressed two of the pro-inflammatory cytokines, IL-6
and IL-1β, but not TNF-α, in LPS-stimulated RAW264.7
cells. No significant suppression of TNF-α by ASEA pre-
treatment might be due to TNF-α secretion reached the
maximum at a shorter duration of incubation, and thus
IL-6 and IL-1β were the more sensitive cytokines for signif-
icant suppression in RAW264.7 cells under 48 hr-incuba-
tion in our study [44]. Nevertheless, the dose of 25 mg/kg
BW ASEA supplement for in vivo study derived from 50
μg/ml tested in vitro according to a previous report [28]
also showed suppression of serum IL-6, IL-1β and TNF-α,
which indicate consistent results from in vitro and in vivo
anti-inflammatory screening strategies.
In addition, ASEA not only inhibits IL-6 secretion in a
dose-dependent manner but also reduces mRNA expres-
sion (Figure 3). Consistently, ASEA suppresses NF-κB acti-
vation, suggesting that the suppressive effect of ASEA on
pro-inflammatory cytokines may involve the inhibition of
NF-κB activation [45]. The trans-activation assay by the
transient transfection of luciferase reporter plasmid to the
cell line is a tool for massive screening [46,47]. A NF-κB-
dependent luciferase construct containing three copies of
an NF-κB binding site was used in this study to further
confirm the anti-inflammatory effect of ASEA. NF-κB
binding sites are involved in the regulation of many genes,
such as cytokines and chemokines [45]. The reduction of
luciferase assay and NF-κB DNA-binding activity by ASEA
confirms the anti-inflammatory effect of ASEA, and sug-
gests that both murine macrophage cell lines and NF-κB-
dependent luciferase report assays are efficient methods
for screening in future studies.
Which component of ASEA exerts this anti-inflammatory
effect is now under investigation. Though coumestrol, the
major phytoestrogen in alfalfa sprouts, was also tested in
the experiment, the results showed that TNF-α, IL-6, and
IL-1β secretions from LPS-stimulated RAW264.7 cells
were not affected by 5–500 nM coumestrol pre-treatment
(data not shown). This may exclude coumestrol as an
effective component. By bioactivity-guided chromato-
graphic fractionation, the major bioactive compounds are
loliolide, 4-hydroxy-6-nonadecyl-tetrahydro-pyran-2-
one, and flavonoids such as liquiritigenin and isoliquirit-
igenin, that exerting significant inhibition of IL-6 and IL-
1β secretions from LPS-stimulated peritoneal macro-
phages of BALB/c mice. The isolation and characterization
of anti-inflammatory effect of these compounds are
undergoing in our laboratory.
In conclusion, this study demonstrated that alfalfa sprouts
extract in ethyl acetate significantly suppresses serum pro-
duction of pro-inflammatory cytokines and increases sur-
vival in LPS-challenged mice.
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